High-Throughput Screening for mTORC1/mTORC2 Kinase Inhibitors Using a Chemiluminescence-Based ELISA Assay

被引:7
作者
Bhagwat, Shripad V. [1 ]
Kahler, Jennifer [1 ]
Yao, Yan [1 ]
Maresca, Paul
Brooks, Maureen
Crew, Andy
Boisclair, Michael
Pachter, Jonathan A. [1 ]
机构
[1] OSI Pharmaceut Inc, Dept Canc Biol, Farmingdale, NY 11735 USA
关键词
MAMMALIAN TOR; MTOR; RAPAMYCIN; PHOSPHORYLATION; TARGET;
D O I
10.1089/adt.2008.0183
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A high-throughput chemiluminescence and ELISA-based biochemical assay to identify mTORC1/mTORC2 kinase inhibitors is described. These mTOR complexes were isolated from HeLa whole cell lysate using mTOR antibodies and in-well immunoprecipitation. The integrity and purity of the mTORC1 and mTORC2 immunocomplexes were confirmed by western blotting. Full-length recombinant 4E-BP1 was used as a substrate and the catalytic activity was measured by detection of p4E-BP1 [T37/46] by a chemiluminescence method. The performance of this assay that can be used to identify dual mTORC1 and mTORC2 kinase inhibitors in a high-throughput 384-well format is described.
引用
收藏
页码:471 / 478
页数:8
相关论文
共 13 条
[1]   RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1 [J].
Burnett, PE ;
Barrow, RK ;
Cohen, NA ;
Snyder, SH ;
Sabatini, DM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (04) :1432-1437
[2]   Targeting the mTOR signaling network in cancer [J].
Chiang, Gary G. ;
Abraham, Robert T. .
TRENDS IN MOLECULAR MEDICINE, 2007, 13 (10) :433-442
[3]   Antitumor activity of rapamycin in a phase I trial for patients with recurrent PTEN-Deficient glioblastoma [J].
Cloughesy, Tim F. ;
Yoshimoto, Koji ;
Nghiemphu, Phioanh ;
Brown, Kevin ;
Dang, Julie ;
Zhu, Shaojun ;
Hsueh, Teli ;
Chen, Yinan ;
Wang, Wei ;
Youngkin, David ;
Liau, Linda ;
Martin, Neil ;
Becker, Don ;
Bergsneider, Marvin ;
Lai, Albert ;
Green, Richard ;
Oglesby, Tom ;
Koleto, Michael ;
Trent, Jeff ;
Horvath, Steve ;
Mischel, Paul S. ;
Mellinghoff, Ingo K. ;
Sawyers, Charles L. .
PLOS MEDICINE, 2008, 5 (01) :139-151
[4]   Mammalian TOR: A homeostatic ATP sensor [J].
Dennis, PB ;
Jaeschke, A ;
Saitoh, M ;
Fowler, B ;
Kozma, SC ;
Thomas, G .
SCIENCE, 2001, 294 (5544) :1102-1105
[5]   PROTEIN SERINE THREONINE KINASES [J].
EDELMAN, AM ;
BLUMENTHAL, DK ;
KREBS, EG .
ANNUAL REVIEW OF BIOCHEMISTRY, 1987, 56 :567-613
[6]  
Gingras AC, 2001, GENE DEV, V15, P2852
[7]   Defining the role of mTOR in cancer [J].
Guertin, David A. ;
Sabatini, David M. .
CANCER CELL, 2007, 12 (01) :9-22
[8]   Dysregulation of the TSC-mTOR pathway in human disease [J].
Inoki, K ;
Corradetti, MN ;
Guan, KL .
NATURE GENETICS, 2005, 37 (01) :19-24
[9]   Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive [J].
Jacinto, E ;
Loewith, R ;
Schmidt, A ;
Lin, S ;
Rüegg, MA ;
Hall, A ;
Hall, MN .
NATURE CELL BIOLOGY, 2004, 6 (11) :1122-U30
[10]   Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex [J].
Sarbassov, DD ;
Guertin, DA ;
Ali, SM ;
Sabatini, DM .
SCIENCE, 2005, 307 (5712) :1098-1101